Zydus Lifesciences receives USFDA approval for Ivermectin Cream

6 Aug 2022 , 01:33 AM

Zydus Lifesciences has received final approval from the United States Food and Drug Administration USFDA to market Ivermectin Cream 1Percentage USRLD Soolantra Ivermectin Cream is a used for the treatment of inflammatory lesions of rosacea The drug will be manufactured at the groups topical manufacturing facility at Ahmedabad India Ivermectin Cream had annual sales of USD 176 million in the United States according to IQVIA data IQVIA MAT June 2022